SANOFI INDIA
Quarterly Results Analysis [Dec2023]
SANOFI INDIA Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹694 Cr | ₹715 Cr | ₹706 Cr | ₹737 Cr | ₹672 Cr | ₹692 Cr | ₹699 Cr | ₹707 Cr |
Expenses | ₹507 Cr | ₹506 Cr | ₹528 Cr | ₹507 Cr | ₹505 Cr | ₹510 Cr | ₹538 Cr | ₹513 Cr |
Operating Income | ₹187 Cr | ₹209 Cr | ₹178 Cr | ₹230 Cr | ₹167 Cr | ₹182 Cr | ₹161 Cr | ₹195 Cr |
Other Income | ₹12 Cr | ₹12 Cr | ₹16 Cr | ₹26 Cr | ₹20 Cr | ₹11 Cr | ₹16 Cr | ₹24 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr |
Profit Before Tax | ₹189 Cr | ₹210 Cr | ₹183 Cr | ₹264 Cr | ₹190 Cr | ₹182 Cr | ₹166 Cr | ₹326 Cr |
Profit After Tax | ₹138 Cr | ₹152 Cr | ₹123 Cr | ₹190 Cr | ₹131 Cr | ₹131 Cr | ₹120 Cr | ₹238 Cr |
EPS | ₹59.87 | ₹66.17 | ₹53.43 | ₹82.78 | ₹56.91 | ₹56.91 | ₹52.35 | ₹103.65 |
Industry Peers & Returns | 1W | 1M | 1Y |
SANOFI INDIA | 0.4% | -15.6% | 33.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
SANOFI INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -2.90 % |
Y-o-Y | 3.27 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹694 Cr | -2.90 | |
Sep2023 | ₹715 Cr | 1.20 | |
Jun2023 | ₹706 Cr | -4.13 | |
Mar2023 | ₹737 Cr | 9.61 | |
Dec2022 | ₹672 Cr | -2.89 | |
Sep2022 | ₹692 Cr | -1.06 | |
Jun2022 | ₹699 Cr | -1.09 | |
Mar2022 | ₹707 Cr | - |
SANOFI INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -10.12 % |
Y-o-Y | 12.28 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹187 Cr | -10.12 | |
Sep2023 | ₹209 Cr | 17.00 | |
Jun2023 | ₹178 Cr | -22.49 | |
Mar2023 | ₹230 Cr | 37.75 | |
Dec2022 | ₹167 Cr | -8.25 | |
Sep2022 | ₹182 Cr | 12.91 | |
Jun2022 | ₹161 Cr | -17.17 | |
Mar2022 | ₹195 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -7.44 % |
Y-o-Y | 8.74 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 27.01% | -7.44 | |
Sep2023 | 29.18% | 15.61 | |
Jun2023 | 25.24% | -19.15 | |
Mar2023 | 31.22% | 25.68 | |
Dec2022 | 24.84% | -5.52 | |
Sep2022 | 26.29% | 14.11 | |
Jun2022 | 23.04% | -16.25 | |
Mar2022 | 27.51% | - |
SANOFI INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -9.53 % |
Y-o-Y | 5.19 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹138 Cr | -9.53 | |
Sep2023 | ₹152 Cr | 23.84 | |
Jun2023 | ₹123 Cr | -35.45 | |
Mar2023 | ₹190 Cr | 45.45 | |
Dec2022 | ₹131 Cr | 0.00 | |
Sep2022 | ₹131 Cr | 8.72 | |
Jun2022 | ₹120 Cr | -49.50 | |
Mar2022 | ₹238 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -6.85 % |
Y-o-Y | 1.85 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 19.84 % | -6.85 | |
Sep2023 | 21.3 % | 22.34 | |
Jun2023 | 17.41 % | -32.65 | |
Mar2023 | 25.85 % | 32.70 | |
Dec2022 | 19.48 % | 2.96 | |
Sep2022 | 18.92 % | 9.87 | |
Jun2022 | 17.22 % | -48.93 | |
Mar2022 | 33.72 % | - |
SANOFI INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -9.52 % |
Y-o-Y | 5.20 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹59.87 | -9.52 | |
Sep2023 | ₹66.17 | 23.84 | |
Jun2023 | ₹53.43 | -35.46 | |
Mar2023 | ₹82.78 | 45.46 | |
Dec2022 | ₹56.91 | 0.00 | |
Sep2022 | ₹56.91 | 8.71 | |
Jun2022 | ₹52.35 | -49.49 | |
Mar2022 | ₹103.65 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD